IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $96,336,933 | -23.0% | 2,448,829 | -52.4% | 15.80% | -35.2% |
| Q1 2023 | $125,083,401 | +13.6% | 5,141,118 | 0.0% | 24.38% | +25.5% |
| Q4 2022 | $110,071,336 | +58.2% | 5,141,118 | +32.6% | 19.43% | -6.9% |
| Q3 2022 | $69,570,000 | +148.2% | 3,877,903 | +33.1% | 20.87% | +75.2% |
| Q2 2022 | $28,035,000 | -33.8% | 2,914,250 | +15.8% | 11.91% | -30.0% |
| Q1 2022 | $42,360,000 | +45.5% | 2,516,920 | +44.5% | 17.00% | +24.7% |
| Q4 2021 | $29,113,000 | – | 1,741,228 | – | 13.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |